Clinical trial
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage Non-small Cell Lung Cancer HAMLET Study
NCT02488850 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage Non-small Cell Lung Cancer HAMLET Study
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- April 5, 2022
- Enrollment
- 32 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer